Internationally Recognized Urologist, Robotic Surgeon and Researcher Dr. Andrew J. Stephenson Joins Associated Medical Professionals of NY

Associated Medical Professionals of NY (A.M.P.) is pleased to announce that Andrew J. Stephenson, MD, MBA, FACS, FRCS(C) has joined its care team. Specialty trained in urologic oncology and robotics, Dr. Stephenson has vast experience in diagnosing and treating urologic cancers using the latest minimally invasive technologies and more conventional approaches. Dr. Stephenson has performed more than 2,000 robotic urology surgeries in his career.

Associated Medical Professionals of NY is a leading multi-specialty practice spanning 19 locations in Central New York, including ten offices and nine hospitals. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and specialty related services in the nation, which is backed by NMS Capital.

Christopher M. Pieczonka, MD, Chief Executive Officer of Associated Medical Professionals of NY and Corporate Director of Clinical Research of U.S. Urology Partners, stated, “A.M.P. is very proud to have Dr. Andrew Stephenson join our practice. We are so excited to welcome a world renown expert and former Director of Urologic Oncology at the Cleveland Clinic to enhance and elevate the care of our local cancer patients. We look forward to the new skills and expertise that Dr. Stephenson will contribute that will put us on par with National Cancer Institute designated cancer centers.”

Dr. Andrew Stephenson said, “I am committed to excellence in patient care, research and innovations in urology. I am excited to join the team at A.M.P. as it provides me an opportunity to deliver innovative, compassionate and high-quality care to patients with complex urological problems, including cancers of the prostate, bladder, kidney and testis, BPH and prostate problems, and PSA screening. I am honored to join a team of like-minded and skilled professionals who are aligned in A.M.P.’s goals: to deliver world-class and comprehensive urological care to the people of the Syracuse community and upstate New York.”

“I am passionate about urological problems and the care of my patients. I endeavor to be my best every day for my patients. I have an unwavering commitment to developing and adopting the most effective treatments for my patients and advancing the field for future patients through clinical trials,” said Dr. Stephenson. “The state-of-the-art facilities at A.M.P. will enable me to deliver the most advanced and innovative urological care for my patients. We endeavor to be at the forefront of urological care, offering patients the spectrum of medical and surgical treatment for their urological problems.”

To learn more about Dr. Stephenson and A.M.P. or to schedule an appointment, please visit www.ampofny.com, www.ampofny.com/physicians/andrew-j-stephenson-md/ or call (315) 478-4185.                                                                                                                                                                                             

About Dr. Andrew J. Stephenson

Andrew J. Stephenson, MD, MBA, FACS, FRCS(C) is an internationally recognized urologist, robotic surgeon and researcher. Before joining Associated Medical Professionals of NY, he served as Director of Urologic Oncology at Rush University Medical Center, Director of the Center of Urologic Oncology at Cleveland Clinic’s Glickman Urological and Kidney Institute and a staff member of the Taussig Cancer Institute. His clinical and research focus is on the treatment of patients with cancers of prostate, bladder and testis. He has published over 125 articles in peer-reviewed journals since 2002 on issues related to prostate, bladder and testis cancer, many of which have received international mainstream media attention. He has been invited to speak on these subjects at major international medical conferences.

Dr. Stephenson is board-certified in urology by the American Board of Urology and the Royal College of Physicians and Surgeons of Canada. He has received several awards from organizations such as the Prostate Cancer Foundation, American Society of Clinical Oncology and Society of Urologic Oncology. He is listed as one of the Best Doctors in America. He received the Urology Teacher of the Year award while at Rush University and Cleveland Clinic.

Dr. Stephenson has received grant support for prostate cancer research from the Robert Wood Johnson Foundation. His research focus is on the development of prognostic statistical models called nomograms. These prognostic models provide accurate predictions of treatment outcome for prostate cancer and are widely used for patient counseling. He is on the editorial board for several urology journals, including Urology, and is an ad hoc reviewer for Journal of the National Cancer Institute, Journal of Clinical Oncology and Journal of Urology.

For patients with prostate cancer, Dr. Stephenson performs both nerve-sparing robotic prostatectomy using latest state-of-art approaches. The decision to perform either robotic or open prostatectomy is tailored to the specifics of each patient’s cancer and preferences. For patients with bladder cancer, Dr. Stephenson also performs robotic nerve-sparing radical cystectomy and orthotopic urinary diversion (neobladder or Studer) for both men and women. He is highly skilled on minimally invasive robotic approaches for kidney tumors and advanced kidney cancers. For select patients with testicular cancer, Dr. Stephenson performs robotic nerve-sparing lymph node dissection. He also has vast experience in minimally invasive treatments for BPH and voiding dysfunction. He has also been a pioneer in the development of biomarkers and image-guided diagnostic approaches for prostate cancer diagnosis and treatment.

About Associated Medical Professionals of NY (A.M.P.)

Associated Medical Professionals of New York (A.M.P.) is a multi-specialty medical practice based in Syracuse serving the Central New York region. Established in 2008, A.M.P. has grown to become one of the largest multi-specialty groups of its kind in the area that strives to provide quality care at each of its ten offices and nine hospital locations. As a pivotal point of care in each community, A.M.P. is able to provide continuity of care for a vast population of patients. A.M.P. maintains a robust suite of services, including advanced urological care, robotic surgery, cancer care, radiation oncology, pathology, lithotripsy, imaging and clinical research. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.ampofny.com and www.us-uro.com.

Associated Medical Professionals of NY Adds Robert Creaven as Chief Operating Officer

Associated Medical Professionals of NY (A.M.P.) is pleased to announce that Robert Creaven has been named Chief Operating Officer. A seasoned healthcare executive with more than 25 years of experience with physician organizations, Creaven will manage operations of A.M.P.’s growing clinical network in the Central New York region.

Associated Medical Professionals of NY is a leading multi-specialty practice spanning 19 locations in Central New York, including ten offices and nine hospitals. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and specialty related services in the nation, which is backed by NMS Capital.

Angelo R. DeRosalia, M.D., Chairman and CEO of Associated Medical Professionals of NY, and President and Board Member of U.S. Urology Partners, stated, “We are excited to have Robert Creaven join the team at A.M.P. and U.S. Urology Partners.  Robert brings a wealth of real-world experience and success to the organization, which will undoubtedly translate to achieving our goals and aspirations.”

Robert Creaven, Chief Operating Officer of Associated Medical Professionals of NY, stated, “I am honored to join Associated Medical Professionals of NY and impressed with the highly skilled physician leaders and their care teams, who are focused on delivering the best care to patients first and foremost. After working with physician organizations in the region my entire career, it’s clear to me the innovation and improved access to medical care that A.M.P. provides to communities in Central New York. A.M.P. enables patients to receive comprehensive, advanced care close to home.”

“By working with Associated Medical Professionals of NY and U.S. Urology Partners, I look forward to not only expanding medical services locally, but being part of a best-in-class integrated healthcare platform recognized for delivering effective, efficient and innovative care in communities across the country,” added Creaven. “I am excited to further develop and grow the A.M.P. practice, from general medical and urological services, to advances in cancer care, radiation oncology, clinical research, ambulatory surgery, robotics and more.”

Robert Creaven has more than two decades of experience finding innovative ways to expand services and improve access to care for physician organizations. He is well-versed in managing multi-site operations, negotiating high-level contracts and building lasting relationships with vendors, clients and partners.

Creaven previously served as Chief Operating Officer of Adjuvant Health, an MSO created by Allied Physicians Group, and one of the largest private medical partnerships in the New York metropolitan area comprised of more than 150 physicians in 34 locations. His background includes serving as Director of Business Development for practice management provider NAPA Management Services, as well as Director of New Business Development and Operations for Nassau Radiologic Group, offering diagnostic radiology, women’s imaging and radiation oncology through 18 diagnostic and therapeutic offices. Early in his career, Creaven supervised client accounts for Tritech Healthcare Management, providing billing services for more than 40 hospitals and other healthcare entities.

Creaven is a graduate of Long Island University, where he received his Master of Science in Public/Health Administration and Bachelor of Science in Healthcare Administration. He also attended SUNY Farmingdale, where he earned an Associate of Science degree in Computer Information Systems. Creaven received a Six Sigma Healthcare Black Belt from Villanova University. He is designated by the Medical Group Management Association (MGMA) as a Certified Medical Practice Executive.

To learn more about Associated Medical Professionals of NY or to schedule an appointment with the A.M.P. care team, please visit www.ampofny.com or call (315) 714-2559.

About Associated Medical Professionals of NY (A.M.P.)

Associated Medical Professionals of New York (A.M.P.) is a multi-specialty medical practice based in Syracuse, New York, serving the Central New York region. Established in 2008, A.M.P. has grown to become one of the largest multi-specialty groups of its kind in the area that strives to provide quality care at each of its ten offices and nine hospital locations. As a pivotal point of care in each community, A.M.P. is able to provide continuity of care for a vast population of patients. A.M.P. maintains a robust suite of ancillary services, including radiation oncology, pathology, lithotripsy, imaging and clinical research. A.M.P.’s provider base consists of more than 30 physicians and numerous clinical support staff practicing in 19 locations. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.ampofny.com and www.us-uro.com.

Florida Urology Center Joins Forces with U.S. Urology Partners

U.S. Urology Partners announced today its strategic partnership with Florida Urology Center, a full-service specialty group which has set the standard of care in the region for three decades. Florida Urology Center provides comprehensive services in five locations throughout Florida, including Ormond Beach, Port Orange, Orange City, New Smyrna Beach and Palm Coast.

U.S. Urology Partners is one of the nation’s largest independent providers of urological and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The rapidly growing U.S. Urology Partners clinical network now consists of more than 40 locations throughout the East Coast and Midwest. U.S. Urology Partners partnered with NMS Capital in 2018 to support urology practices in communities across the country.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “We are honored to welcome Florida Urology Center, which is well-known for its quality care and advanced technology, including a state-of-the-art surgery center. The addition of Florida Urology Center expands our multi-regional clinical network, which now spans the East Coast and the Midwest. Through collaboration among our partner practices, we are able to make an even greater impact on delivering the highest level of urological care in the communities we serve.”

Greg A. Parr, M.D., of Florida Urology Center stated, “We are pleased to join U.S. Urology Partners and share a common dedication to providing the highest quality of comprehensive urological care. Our partnership with U.S. Urology Partners will enable us to continue improving the lives of patients by offering the most current diagnostic and therapeutic alternatives available in the region and investing in the latest technologies. Through the support provided by U.S. Urology Partners to our growing practice, the Florida Urology Center care team can remain focused on our most important priority—our patients.”

U.S. Urology Partners assists urology practices through an experienced team of healthcare executives and resources. The practices benefit from U.S. Urology Partners’ substantial investment in people, technology and services to better address patient and employee needs in the communities they serve, while being well positioned for continued growth.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners clinical network consists of more than 40 locations throughout the East Coast and Midwest. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit www.us-uro.com.

 About Florida Urology Center

Established in 1992, Florida Urology Center has five convenient locations throughout Florida, including Ormond Beach, Port Orange, Orange City, New Smyrna Beach and Palm Coast. Florida Urology Center is committed to providing quality healthcare to its patients through education, training, clinical research, and support. The practice is dedicated to improving the lives of its patients by offering the most current diagnostic and therapeutic alternatives available. Facilities are equipped with the latest state-of-the art technology to provide the safest and most comprehensive care. Most of the surgeries are performed in Florida Urology Center’s outpatient surgery center licensed by the state of Florida and certified by Medicare. For more information about Florida Urology Center, please visit www.floridaurology.com.

U.S. Urology Partners Adds Mandy Lawrence and Corrinne Ehlert to C-Suite

Experienced Health Executives Fill Roles of Chief Operating Officer and Chief Compliance Officer

U.S. Urology Partners, one of the country’s largest independent providers of urology and related specialty services, today announced the addition of two nationally recognized healthcare leaders to its senior executive team. Mandy Lawrence has joined the rapidly growing business as Chief Operating Officer, and Corrinne Ehlert has been named Chief Compliance Officer.

U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners clinical network now consists of 24 offices spanning the Midwest and Northeast. Given the interest in U.S. Urology Partners’ unique model of supporting practices, discussions are underway with numerous groups regarding partnership opportunities.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “We are very pleased to welcome Mandy Lawrence and Corrinne Ehlert to the U.S. Urology Partners team. Their decades of experience in healthcare operations and backgrounds in providing outstanding clinical care will be invaluable as we continue to enhance the urological services in the communities we serve. In addition to sharing best practices and team efficiencies,  Mandy and Corrinne will play a critical role as we expand our geographic footprint.”

Mandy Lawrence, Chief Operating Officer

Lawrence an experienced multi-site healthcare operational leader who has distinguished herself throughout her career. With a nursing degree and MBA, she possesses a unique balance of operational expertise and clinical leadership. Before joining U.S. Urology Partners, Lawrence was Division Vice President at Center for Autism and Related Disorders, managing the East Division comprised of 20 states. Lawrence previously served as Regional Vice President of Operations for Compassus. During her tenure, her region was recognized as a leader in growth, profitability and quality.

Lawrence received a Bachelor of Arts degree in biology from William Woods University and earned her Bachelor of Science in nursing from the University of Missouri at Columbia. Lawrence returned to William Woods University for her graduate work, where she was awarded an MBA with healthcare administration emphasis.

Corrinne Ehlert, Chief Compliance Officer

Ehlert is responsible for the development and execution of U.S. Urology Partners’ Compliance Program. Ehlert is an experienced healthcare leader with three decades of proven success in performance and outcomes. She brings broad and deep expertise as a healthcare services professional focused on organizational leadership, compliance, and clinical and operational excellence. Ehlert joins U.S. Urology Partners from Three Oaks Hospice, a private equity-backed company with multi-state operations, where she led Compliance, Quality and Clinical Operations. She previously served at Alive Hospice as Vice President of Operational Improvement and Compliance.

Ehlert holds a bachelor’s degree in healthcare administration from St. Joseph’s College in Maine and an associate degree in nursing from University of Nevada Las Vegas.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. The U.S. Urology Partners practice continues to grow rapidly and currently consists of a network of 24 offices throughout the Midwest and Northeast. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital is building a leading provider of urological services. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information, please visit the U.S. Urology Partners website at www.us-uro.com.

U.S. Urology Partners Adds Scott Clatur as Chief People Officer

U.S. Urology Partners, one of the country’s largest independent providers of urology and related specialty services, today announced that Scott Clatur has joined the rapidly growing business as Chief People Officer. A nationally recognized human resources and talent strategy visionary, Clatur has more than two decades of experience leading high growth healthcare and technology organizations.

U.S. Urology Partners was formed in 2018 to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The U.S. Urology Partners clinical network now consists of 24 offices in Ohio and New York through partner practices Central Ohio Urology Group and Associated Medical Professionals of NY. Given the tremendous interest in U.S. Urology Partner’s unique model of supporting practices, discussions are underway with numerous groups regarding partnership opportunities.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, stated, “I am very excited to introduce Scott Clatur to U.S. Urology Partners in the new role of Chief People Officer. Scott has spent more than 20 years implementing talent strategies that drive growth, support business transformation, and build best-in-class cultures for both healthcare and technology businesses. His leadership will be crucial in helping us shape our future workplace and employee experience strategy while growing and developing the most important part of our company’s business, our people.”

Prior to joining U.S. Urology Partners, Clatur served as Head of People at Built Technologies, and previously held senior HR and talent leadership roles at Visual Lease, Health Quest, Henry Ford Health System and Best Buy. He has a record of success developing strategies to lead through rapid growth while driving a world-class experience that fosters an innovative and inclusive environment.

Scott Clatur, Chief People Officer of U.S. Urology Partners, stated, “It’s an honor to join an organization with such an important mission and at such a critical time. When you invest in people, people invest in you. What I have seen of the culture at U.S. Urology Partners shows true commitment to not only serving all of our team members, but also supporting one another as colleagues.”

“I’m excited to help continue scaling U.S. Urology Partners and its core functions while also helping to shape the culture and support our people to achieve our goals. I look forward to being a part of the solution to assist urology practices in delivering exceptional care to patients in communities across the country,” said Clatur.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. Through Central Ohio Urology Group and Associated Medical Professionals of NY, the U.S. Urology Partners practice consists of a network of 24 offices throughout Ohio and New York. U.S. Urology Partners was formed to support urology practices with an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital intends to build a leading provider of urological services through an acquisition strategy. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners and employment opportunities, please visit the company’s website at www.us-uro.com.

U.S. Urology Partners Names Corina Tracy as Chief Executive Officer

U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty services, today announced that Corina Tracy will assume the position of Chief Executive Officer effective January 1, 2022.

U.S. Urology Partners was formed in 2018 to support urology practices with an experienced team of healthcare executives and resources, and is backed by NMS Capital. The rapidly growing U.S. Urology Partners clinical network consists of 24 offices in Ohio and Upstate New York through partner practices Central Ohio Urology Group and Associated Medical Professionals of NY.

Corina Tracy’s background includes nearly two decades with post-acute provider Compassus, where she was integral in growing the business from 20 locations to nearly 200 locations in 30 states. Tracy joined U.S. Urology Partners in 2021 as Chief Operating Officer. Mark Cherney, who has been serving as Chief Executive Officer since the founding of U.S. Urology Partners, will remain actively involved as Executive Chairman.

Mark Cherney, Executive Chairman and Chief Executive Officer of U.S. Urology Partners, stated, “It has been both a privilege and honor to serve as the founding CEO of U.S. Urology Partners. During the past four years, we have experienced many positive changes in both our Central Ohio and Upstate New York operations. As Executive Chairman, I will primarily be involved in strategy and development with a focus in support of Corina Tracy’s vision for growth in an ever-changing urology market. I couldn’t be more pleased to support Corina as the future generation leader and innovator for years to come.”

Corina Tracy  stated, “It has been a pleasure to work with the U.S. Urology Partners team, and I look forward to fulfilling our mission of supporting urology practices in providing optimal care to their patients. The ability to share best practices and optimize operations through the involvement of a partner like U.S. Urology Partners is a tremendous advantage during this time of increasingly complex healthcare regulations, rapidly advancing technologies and heightened consumer expectations.”

During her almost 20-year tenure at Compassus, Tracy held several leadership roles, including Executive Vice President and Chief Operating Officer, and President, Hospice & Palliative Care. She most recently served as Executive Vice President, Chief Quality, Innovation and Integration Officer, leading Compassus’ focus on clinical and organizational excellence. Her efforts helped guide Compassus’ 6,000 team members who provide quality care and manage patients’ advanced illnesses in partnership with health systems and long-term care partners.

A certified hospice and palliative nurse and end-of-life nursing educator for many years, Tracy’s experience informs her leadership and unwavering focus on providing an optimal experience for patients and their families. She has served on the Board of Directors of the National Hospice and Palliative Care Organization and been a member of the Legislative Affairs Committee and Regulatory Committee. Tracy is a member of Leadership Health Care, an initiative of the Nashville Health Care Council, and the Women Business Leaders of the U.S. Health Care Industry Foundation (WBL). Tracy received her nursing degree from Scott College and holds a Bachelor of Science in Business Administration from Upper Iowa University. She was named by Nashville Medical News to Women to Watch, an honor recognizing the top women healthcare leaders in the region.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced cancer treatment and other ancillary services. Through Central Ohio Urology Group and Associated Medical Professionals of NY, the U.S. Urology Partners practice consists of a network of 24 offices throughout Ohio and Upstate New York. U.S. Urology Partners was formed to support urology practices through an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital intends to build a leading provider of urological services through an acquisition strategy. The U.S. Urology Partners corporate office is in Nolensville, Tennessee, just outside of Nashville. For additional information about U.S. Urology Partners, please visit the company’s website at www.us-uro.com.

U.S. Urology Partners Adds David M. Albala, M.D., to Board of Directors

U.S Urology Partners announced today that David M. Albala, M.D., has joined its Board of Directors. A board certified urologist considered an authority in laparoscopic and robotic urological surgery, Dr. Albala is internationally recognized for his decades of leadership in the field of urology. His contributions include being part of the team that performed the first laparoscopic nephrectomy in humans. An educator and researcher with 160 publications in peer-reviewed journals and 6 books, Dr. Albala’s experience includes operative demonstrations in more than 30 countries in addition to serving as a White House Fellow.

U.S. Urology Partners is one of the nation’s largest independent providers of urological and related specialty services, including general urology, surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. Through its operations with Central Ohio Urology Group and recently announced partnership with Associated Medical Professionals of New York, the clinical network of U.S. Urology Partners now consists of 24 locations in the Ohio and Upstate New York regions.

Mark Cherney, Chief Executive Officer of U.S. Urology Partners, stated, “We are thrilled with Dr. David Albala joining the U.S. Urology Partners board alongside Dr. Angelo DeRosalia, his partner at Associated Medical Professionals of NY. David’s expertise and knowledge of the U.S. urology marketplace will be helpful as we continue to build our presence.”

U.S. Urology Partners was formed in 2018 to support urology practices through an experienced team of healthcare executives and resources, while serving as a platform upon which the company’s investment partner, NMS Capital, intends to build a leading provider of urological services through an acquisition strategy.

Angelo R. DeRosalia, M.D., President of U.S. Urology Partners, and Chairman and Chief Executive Officer of Associated Medical Professionals of NY, said, “Dr. Albala is a great addition to the U.S. Urology Partners board. His decades of experience and wealth of knowledge will undoubtedly serve U.S. Urology Partners well as we move forward in the future.”

David M. Albala, M.D., stated, “I am looking forward to working with U.S. Urology Partners. I believe my experience in academic urology at both Loyola University and Duke University will provide a different perspective, especially on incorporating cutting edge technology in the private sector.”

Dr. David M. Albala is a board certified urologist who is fellowship-trained in endourology, laparoscopy and robotic surgery. He graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr. Albala was an endourology fellow at Washington University Medical Center in St. Louis, Missouri, under the direction of Ralph V. Clayman. At Washington University, he was part of the team that performed the first laparoscopic nephrectomy in humans. He practiced at Loyola University Medical Center in Chicago and rose from the ranks of Instructor to Full Professor in Urology and Radiology in 8 years. After 10 years at Loyola, he became a tenured Professor of Surgery (Urology) at Duke University in Durham, North Carolina. At Duke, he was Co-Director of the Endourology fellowship and the Director for the Center of Minimally Invasive and Robotic Urological Surgery. He has overall 160 publications in peer-reviewed journals and has authored 3 textbooks in endourology and 3 books in general urology. He is currently the Editor-in-Chief of the Journal of Robotic Surgery and serves on the editorial board for Current Opinions in Urology, Reviews in Urology, and Urology Index and Reviews. In addition, he serves as a reviewer for 8 other surgical journals. He is currently on the Board of Directors of the Large Urology Group Practice Association (LUGPA). LUGPA is the only nonprofit urology trade association that represents over 25% of practicing urologists in the United States.

At the present time, he is Chief of Urology at Crouse Hospital in Syracuse, New York. He is considered a national and international authority in laparoscopic and robotic urological surgery and has been an active teacher in this area for over 20 years. His research and clinical interest have focused on robotic urologic surgery. In addition, other clinical interest includes minimally invasive treatments for benign prostatic hypertrophy (BPH) and the use of fibrin sealants in surgery. He has been a Visiting Professor at numerous institutions across the United States as well as overseas in countries such as India, China, Iceland, Germany, France, Japan, Brazil, Australia and Singapore. He has done operative demonstrations in over 32 countries and 23 states. He has trained 16 fellows in endourology and advanced robotic surgery.

Dr. Albala is a past White House Fellow (1995-1996), who acted as a special assistant to Federico Peña, Secretary of Transportation, on classified and unclassified public health related issues.

About U.S. Urology Partners
U.S. Urology Partners is one of the nation’s largest independent providers of urology and related specialty services, including general urology, surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. Through Central Ohio Urology Group and Associated Medical Professionals of NY, the U.S. Urology Partners practice now consists of more than 50 providers across a network of 24 offices throughout Ohio and Upstate New York, including a state-of-the-art ambulatory surgery center. U.S. Urology Partners was formed to support urology practices through an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital intends to build a leading provider of urological services through an acquisition strategy. The U.S. Urology Partners corporate offices are in Gahanna, Ohio, and Nolensville, Tennessee, just outside of Columbus and Nashville. For additional information on U.S. Urology Partners, please visit the company’s website at www.us-uro.com.